RxDoctor Payments Data

Melissa Chiles, MD

Anatomic Pathology & Clinical Pathology · Knoxville, TNNPI 1205805272

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $317 and has fallen 54.9% since, to $143 in 2025.

$573in general payments, 2019–2025

Across 30 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$86
  • Ardelyx, Inc.$84
  • Regeneron Healthcare Solutions, Inc.$70
  • Takeda Pharmaceuticals U.S.A., Inc.$66
  • Johnson & Johnson$48
  • Genentech USA, Inc.$39
  • plus $180 from 8 others

What the payments were for

  • Food & beverage$573100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$573 in reported general payments places this provider in the 80th percentile of 234 anatomic pathology & clinical pathology providers in Tennessee.

See all anatomic pathology & clinical pathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$36,498
Medicare patients
279
Services billed
1,189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →